Key Details
Gunars Gaikis
Partner
Smart & Biggar/Fetherstonhaugh
Canada
Applied Filters
Gunars Gaikis
Overview
Gunars Gaikis has more than 25 years’ experience in life sciences intellectual property litigation. He has particularly focused on patent, regulatory and trademark-related litigation for innovative companies in the pharmaceutical and biotechnology areas. He has appeared as lead counsel in many IP cases before the Ontario, Federal and Supreme courts. He is a fellow of the Intellectual Property Institute of Canada, a member of PTMG, and an editorial board member of WIPR Leaders’ sister publication Life Sciences IP Review. He is a frequent speaker at industry events around the world and has had numerous publications on matters related to his practice.
Contact
Participation in Wider Community
- "Clarification of the 'promise' of utility doctrine in Canada," Expert Guides: Patent 2015, March 2015, pp. 88-89
- "The race for market exclusivity," Life Sciences Intellectual Property Review Quarterly, Vol. 2, Issue 2 (2015)
- "Cold Feet in Canada," Life Sciences Intellectual Property Review Quarterly, Vol. 2, Issue 1 (2015)
- "Supreme Court of Canada: VIAGRA patent "void" for insufficient disclosure" (co-authors: J. Sheldon Hamilton and Colin B. Ingram), IP Update — Canada, November 8, 2012
- "Pharmaceutical Patent Litigation is Inevitable — Typically Overlooked Licensing Terms" (co-authors: Junyi Chen, Jeff J. Kang and Rebecca B. Rodal), presented at the Federated Press conference titled "Negotiating & Drafting Bio Pharma Contracts," June 2011
Professional Affiliations
- Fellow, Intellectual Property Institute of Canada
- Member, Pharmaceutical Trade Marks Group
- Member, American Intellectual Property Law Association
- Past long-time Chair of the Patent Committee of the IP Section, Canadian Bar Association
- Editorial board member of LSIPR Newsletter
Academic Affiliations
- "Navigating Jurisdictional Challenges and Quantifying Damages in s. 8 Cases: Critical Views from Both Sides" panel discussion at the Canadian Institute's 11th Annual Forum on Pharma Patents, Toronto, October 2012
- "Damages in Patent Infringement and Section 8 Cases: The View from Both Sides" panel discussion at the Canadian Institute's 10th Annual Forum on Pharma Patents, Toronto, October 2011
- "Strategies in Pharma Patent Litigation," Insight Information's 9th conference on Drug Patents in Canada, Toronto, May 2010
- "Pharma Patents Litigation: Year in Review," panel discussion at The Canadian Institute's 8th Annual Forum on Pharma Patents, Toronto, October 2009
- "Pharma Patent Trials Within Two Years," Insight Information's Drug Patent and Legal Forum, Toronto, May 2009
